ALRM vs ASML

ALRM's Piotroski F-Score of 4/9 indicates weak financial health, signaling potential instability despite moderate profitability and growth. The absence of an Altman Z-Score raises concern about default risk, particularly given a high debt/equity ratio of 1.20. While the company exhibits strong earnings growth (17.9% YoY) and consistent earnings beats (average surprise of 18.19% over last 4 quarters), its valuation at 18.94x P/E is elevated relative to peers and the broader sector. The Graham Number ($30.76) and intrinsic value estimate ($72.57) suggest a significant premium to conservative fair value, driven by growth expectations. Insider selling activity over the past six months further tempers optimism.

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.